Nuo Therapeutics AURX
OTC AURX
$1.29 +0.03 (+2.46%)
As of: Oct 21, 2026 · 12:22 PM EDT

Nuo Therapeutics (AURX) Non-Current Deffered Revenue (2013 - 2026)

Updated

Nuo Therapeutics' Non-Current Deffered Revenue was $857,353 in Q2 2026, down 23.8% from $1.13 million a year earlier.

Analysis

Nuo Therapeutics (AURX) Non-Current Deffered Revenue (2013 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Deffered Revenue at Nuo Therapeutics came in at $975,000.

  • The Q2 2026 figure marks the lowest quarterly Non-Current Deffered Revenue since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn -
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn -
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn -
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn -
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn -
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn -
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn -
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn -
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn -
10 Nuo Therapeutics 60.54 Mn 58.71 Mn 1.17 Mn 857,353.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 857,353.00
Dec 31, 2025 975,000.00
Sep 30, 2025 1.05 Mn
Jun 30, 2025 1.13 Mn
Mar 31, 2016 536,503.00
Dec 31, 2015 637,097.00
Sep 30, 2015 737,692.00
Jun 30, 2015 838,286.00
Mar 31, 2015 938,880.00
Dec 31, 2014 1.04 Mn
Sep 30, 2014 1.14 Mn
Jun 30, 2014 1.24 Mn
Mar 31, 2014 1.34 Mn
Dec 31, 2013 1.44 Mn
Sep 30, 2013 1.54 Mn
API Access

Nuo Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AURX&period=max&api_key=YOUR_API_KEY